Veeva Systems Inc. $VEEV Shares Acquired by American Century Companies Inc.

American Century Companies Inc. increased its position in shares of Veeva Systems Inc. (NYSE:VEEV) by 6.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 501,713 shares of the technology company’s stock after acquiring an additional 28,878 shares during the period. American Century Companies Inc. owned approximately 0.31% of Veeva Systems worth $144,483,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. ASR Vermogensbeheer N.V. increased its holdings in shares of Veeva Systems by 64.2% in the second quarter. ASR Vermogensbeheer N.V. now owns 5,167 shares of the technology company’s stock valued at $1,488,000 after buying an additional 2,020 shares in the last quarter. Stevens Capital Management LP acquired a new stake in shares of Veeva Systems during the second quarter worth $306,000. QRG Capital Management Inc. lifted its holdings in shares of Veeva Systems by 15.7% during the second quarter. QRG Capital Management Inc. now owns 12,771 shares of the technology company’s stock valued at $3,678,000 after purchasing an additional 1,735 shares during the last quarter. Merit Financial Group LLC increased its stake in Veeva Systems by 12.5% in the 2nd quarter. Merit Financial Group LLC now owns 45,247 shares of the technology company’s stock worth $13,030,000 after purchasing an additional 5,042 shares in the last quarter. Finally, Teacher Retirement System of Texas increased its stake in Veeva Systems by 1.9% in the 2nd quarter. Teacher Retirement System of Texas now owns 143,469 shares of the technology company’s stock worth $41,316,000 after purchasing an additional 2,659 shares in the last quarter. 88.20% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

VEEV has been the subject of several recent analyst reports. Jefferies Financial Group reiterated a “buy” rating and issued a $330.00 target price on shares of Veeva Systems in a report on Monday. Wells Fargo & Company upped their price target on shares of Veeva Systems from $300.00 to $326.00 and gave the company an “overweight” rating in a research report on Tuesday, August 26th. BMO Capital Markets started coverage on shares of Veeva Systems in a research report on Thursday, November 13th. They set a “market perform” rating and a $300.00 price objective on the stock. Robert W. Baird boosted their target price on shares of Veeva Systems from $314.00 to $319.00 and gave the company an “outperform” rating in a research note on Friday. Finally, Piper Sandler raised their target price on Veeva Systems from $325.00 to $355.00 and gave the stock an “overweight” rating in a research report on Thursday, August 28th. Eighteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $305.62.

Veeva Systems Price Performance

NYSE VEEV opened at $236.10 on Tuesday. Veeva Systems Inc. has a fifty-two week low of $201.54 and a fifty-two week high of $310.50. The stock’s 50-day moving average is $286.95 and its two-hundred day moving average is $279.11. The firm has a market cap of $38.70 billion, a P/E ratio of 48.48, a price-to-earnings-growth ratio of 2.22 and a beta of 0.98.

Veeva Systems (NYSE:VEEV) last posted its earnings results on Thursday, November 20th. The technology company reported $2.04 earnings per share for the quarter, topping the consensus estimate of $1.95 by $0.09. The firm had revenue of $811.24 million during the quarter, compared to analyst estimates of $792.37 million. Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The company’s revenue for the quarter was up 16.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.75 EPS. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS. Q4 2026 guidance at 1.920-1.920 EPS. On average, equities analysts expect that Veeva Systems Inc. will post 4.35 EPS for the current year.

Insider Activity at Veeva Systems

In related news, SVP Jonathan Faddis sold 14,595 shares of Veeva Systems stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $300.00, for a total value of $4,378,500.00. Following the transaction, the senior vice president owned 8,588 shares in the company, valued at $2,576,400. This trade represents a 62.96% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Thomas D. Schwenger sold 3,350 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total value of $1,005,134.00. Following the completion of the sale, the insider directly owned 23,773 shares in the company, valued at $7,132,850.92. This trade represents a 12.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 24,665 shares of company stock worth $7,438,000. 10.30% of the stock is owned by insiders.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.